HWAM
DCPH
Hennion & Walsh Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-33,942
| Closed | -$432K | – | 884 |
|
|
2023
Q3 | $432K | Sell |
33,942
-6,701
| -16% | -$85.2K | 0.03% | 559 |
|
|
2023
Q2 | $572K | Sell |
40,643
-26,881
| -40% | -$378K | 0.03% | 479 |
|
|
2023
Q1 | $1.04M | Sell |
67,524
-1,881
| -3% | -$29.1K | 0.06% | 347 |
|
|
2022
Q4 | $1.14M | Sell |
69,405
-30,128
| -30% | -$494K | 0.07% | 317 |
|
|
2022
Q3 | $1.84M | Sell |
99,533
-3,702
| -4% | -$68.5K | 0.12% | 205 |
|
|
2022
Q2 | $1.36M | Buy |
103,235
+1,592
| +2% | +$20.9K | 0.08% | 257 |
|
|
2022
Q1 | $942K | Buy |
101,643
+13,015
| +15% | +$121K | 0.05% | 360 |
|
|
2021
Q4 | $866K | Buy |
88,628
+19,087
| +27% | +$187K | 0.04% | 405 |
|
|
2021
Q3 | $2.36M | Buy |
69,541
+6,964
| +11% | +$237K | 0.12% | 221 |
|
|
2021
Q2 | $2.29M | Buy |
62,577
+21,854
| +54% | +$800K | 0.12% | 223 |
|
|
2021
Q1 | $1.83M | Buy |
+40,723
| New | +$1.83M | 0.11% | 248 |
|